{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:53:40Z","timestamp":1776286420036,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust, UK","doi-asserted-by":"crossref","award":["072064"],"award-info":[{"award-number":["072064"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Monitoring patient\u2019s clinical attendance is a crucial means of improving retention in care and treatment programmes. Sickle cell patients\u2019 outcomes are improved by participation in comprehensive care programmes, but these benefits cannot be achieved when patients are lost from clinical care. In this study, patients are defined as loss to follow-up when they did not attend clinic for more than 9 months. Precise information on the retention rate and characteristics of those who are not following their clinic appointments is needed to enable the implementation of interventions that will be effective in increasing the retention to care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      This was a retrospective study involving sickle cell patients registered in the Muhimbili Sickle Cohort in Tanzania. Descriptive and survival analysis techniques both non-parametric methods (Kaplan-Meier estimator and Log-rank test) and semi-parametric method (Cox\u2019s proportional hazard model), were used. A\n                      <jats:italic>p<\/jats:italic>\n                      -value of 0.05 was considered significant to make an inference from the analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 5476 patients were registered in the cohort from 2004 to 2016. Of these, 3350 (58.13%) were actively participating in clinics, while 2126 (41.87%) were inactive, of which 1927 (35.19%) were loss to follow-up. We used data from 2004 to 2014 because between 2015 and 2016, patients were referred to other government hospitals. From the survival analysis results, pediatric (HR: 14.29,95% CI: 11.0071\u201318.5768,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001) and children between 5 and 17\u2009years [HR:2.61,95% CI:2.2324\u20133.0705,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001] patients were more likely to be loss to follow-up than the adult (18 and above years) patients. It was found that patients with above averages for hematocrit (HR: 2.38, 95% CI: 1.0076\u20131.0404,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0039) or mean cell volume (HR: 4.28, (95% CI: 1.0260\u20131.0598,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) were more likely to be loss to follow-up than their counterparts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Loss to follow-up is evident in the cohort of patients in long term comprehensive care. It is, therefore, necessary to design interventions that improve patients\u2019 retention. Suggested solutions include refresher training for health care workers and those responsible for patient follow-up on techniques for retaining patients and comprehensive transition programs to prepare patients who are moving from pediatric to adult clinics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-020-05998-6","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T08:04:06Z","timestamp":1607933046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patterns and patient factors associated with loss to follow-up in the Muhimbili sickle cell cohort, Tanzania"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1682-0236","authenticated-orcid":false,"given":"Upendo","family":"Masamu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael Z.","family":"Sangeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Kandonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesca","family":"Ondengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Ndobho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Mmbando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siana","family":"Nkya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Msami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Makani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"6","key":"5998_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/bjh.14594","volume":"177","author":"F Tluway","year":"2017","unstructured":"Tluway F, Makani J. Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016. Br J Haematol. 2017;177(6):919\u201329. [cited 2019 Feb 11] Available from. https:\/\/doi.org\/10.1111\/bjh.14594.","journal-title":"Br J Haematol"},{"issue":"1","key":"5998_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12878-018-0125-0","volume":"18","author":"J Makani","year":"2018","unstructured":"Makani J, Tluway F, Makubi A, Soka D, Nkya S, Sangeda R, et al. A ten year review of the sickle cell program in Muhimbili national hospital, Tanzania. BMC Hematol. 2018;18(1):1\u201313.","journal-title":"BMC Hematol"},{"issue":"2","key":"5998_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/pbc.24175","volume":"59","author":"B Aygun","year":"2012","unstructured":"Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer. 2012;59(2):386\u201390 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22535620.","journal-title":"Pediatr Blood Cancer"},{"key":"5998_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijans.2015.08.002","volume":"3","author":"LL Mulumba","year":"2015","unstructured":"Mulumba LL, Wilson L. Sickle cell disease among children in Africa: An integrative literature review and global recommendations. Int J Africa Nurs Sci. 2015;3:56\u201364 [cited 2019 Feb 12] Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214139115000207.","journal-title":"Int J Africa Nurs Sci"},{"issue":"17","key":"5998_CR5","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","volume":"115","author":"CT Quinn","year":"2010","unstructured":"Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447\u201352.","journal-title":"Blood."},{"issue":"1","key":"5998_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12874-016-0245-9","volume":"16","author":"A Makubi","year":"2016","unstructured":"Makubi A, Sasi P, Ngaeje M, Novelli EM, Mmbando BP, Gladwin MT, et al. Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania. BMC Med Res Methodol. 2016;16(1):140 Available from: http:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-016-0245-9.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"5998_CR7","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","volume":"14","author":"C Booth","year":"2010","unstructured":"Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. Int J Infect Dis. 2010;14(1):e2\u201312 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971209001453.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"5998_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/pbc.24110","volume":"59","author":"R Colombatti","year":"2012","unstructured":"Colombatti R, Montanaro M, Guasti F, Rampazzo P, Meneghetti G, Giordan M, et al. Comprehensive care for sickle cell disease immigrant patients: A reproducible model achieving high adherence to minimum standards of care. Pediatr Blood Cancer. 2012;59(7):1275\u20139. [cited 2019 Sep 12] Available from. https:\/\/doi.org\/10.1002\/pbc.24110.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"5998_CR9","first-page":"4","volume":"7","author":"A Atreja","year":"2005","unstructured":"Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed. 2005;7(1):4 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16369309.","journal-title":"MedGenMed"},{"issue":"1","key":"5998_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12874-017-0310-z","volume":"17","author":"M Abshire","year":"2017","unstructured":"Abshire M, Dinglas VD, Cajita MIA, Eakin MN, Needham DM, Himmelfarb CD. Participant retention practices in longitudinal clinical research studies with high retention rates. BMC Med Res Methodol. 2017;17(1):30 Available from: https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-017-0310-z.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"5998_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1758-2652-13-49","volume":"13","author":"AT Brennan","year":"2010","unstructured":"Brennan AT, Maskew M, Sanne I, Fox MP. The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa. J Int AIDS Soc. 2010;13(1):49. [cited 2019 Feb 11] Available from. https:\/\/doi.org\/10.1186\/1758-2652-13-49.","journal-title":"J Int AIDS Soc"},{"issue":"01","key":"5998_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-0030-1267080","volume":"2","author":"J Dettori","year":"2011","unstructured":"Dettori J. Loss to follow-up. Evid Based Spine Care J. 2011;2(01):7\u201310 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22956930.","journal-title":"Evid Based Spine Care J"},{"issue":"1","key":"5998_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-6343-3","volume":"19","author":"JN Mutanga","year":"2019","unstructured":"Mutanga JN, Mutembo S, Ezeamama AE, Song X, Fubisha RC, Mutesu-Kapembwa K, et al. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015). BMC Public Health. 2019;19(1):1\u201313.","journal-title":"BMC Public Health"},{"issue":"1","key":"5998_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-6-512","volume":"6","author":"CE Bekolo","year":"2013","unstructured":"Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba regional hospital, Cameroon. BMC Res Notes. 2013;6(1):1\u201316 Available from: BMC Research Notes.","journal-title":"BMC Res Notes"},{"issue":"S2","key":"5998_CR15","doi-asserted-by":"publisher","first-page":"P78","DOI":"10.1186\/1471-2334-14-S2-P78","volume":"14","author":"LC Machumi","year":"2014","unstructured":"Machumi LC, Mtisi E, Andrew I, Sando D, Mkali H, Liu E, et al. Who are they? Identifying risk factors of loss to follow up among HIV+ patients on care and treatment in Dar es Salaam. BMC Infect Dis. 2014;14(S2):P78 Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-S2-P78.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"5998_CR16","doi-asserted-by":"publisher","first-page":"P124","DOI":"10.1186\/1758-2652-13-S4-P124","volume":"13","author":"V Fridman","year":"2010","unstructured":"Fridman V, Bello N, Lasala M. Identifying causes of loss to follow up in newly diagnosed HIV-infected patients. J Int AIDS Soc. 2010;13(Suppl 4):P124. Available from:. https:\/\/doi.org\/10.1186\/1758-2652-13-S4-P124.","journal-title":"J Int AIDS Soc"},{"key":"5998_CR17","first-page":"e46","volume-title":"Possible Risk Factors for Severe Anemia in Hospitalized Sickle Cell Patients at Muhimbili National Hospital, Tanzania: Protocol for a Cross-Sectional Study. Vol. 7, JMIR research protocols","author":"FU Furahini Tluway","year":"2018","unstructured":"Furahini Tluway FU, Mmbando B, Sangeda RZ, Makubi A, Makani J, Tluway F, et al. Possible Risk Factors for Severe Anemia in Hospitalized Sickle Cell Patients at Muhimbili National Hospital, Tanzania: Protocol for a Cross-Sectional Study. Vol. 7, JMIR research protocols; 2018. p. e46. Available from: http:\/\/www.researchprotocols.org\/2018\/2\/e46\/."},{"issue":"1","key":"5998_CR18","doi-asserted-by":"publisher","first-page":"e26735","DOI":"10.1002\/pbc.26735","volume":"65","author":"EE Ambrose","year":"2018","unstructured":"Ambrose EE, Makani J, Chami N, Masoza T, Kabyemera R, Peck RN, et al. High birth prevalence of sickle cell disease in Northwestern Tanzania. Pediatr Blood Cancer. 2018;65(1):e26735. Available from:. https:\/\/doi.org\/10.1002\/pbc.26735.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"5998_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12913-015-0912-2","volume":"15","author":"MN Mberi","year":"2015","unstructured":"Mberi MN, Kuonza LR, Dube NM, Nattey C, Manda S, Summers R. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004\u20132012: a cohort study. BMC Health Serv Res. 2015;15(1):259 Available from: https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-015-0912-2.","journal-title":"BMC Health Serv Res"},{"key":"5998_CR20","volume-title":"RStudio: Integrated Development for R. RStudio","author":"RStudio_Team","year":"2020","unstructured":"RStudio_Team. RStudio: Integrated Development for R. RStudio. 2020; Available from: http:\/\/www.rstudio.com\/."},{"issue":"1","key":"5998_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/1054-139X(95)00073-2","volume":"17","author":"BLUM R","year":"1995","unstructured":"BLUM R. Transition to adult health care: setting the stage. J Adolesc Heal. 1995;17(1):3\u20135 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/1054139X95000732.","journal-title":"J Adolesc Heal"},{"issue":"7","key":"5998_CR22","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/pbc.21974","volume":"52","author":"M McPherson","year":"2009","unstructured":"McPherson M, Thaniel L, Minniti CP. Transition of patients with sickle cell disease from pediatric to adult care: assessing patient readiness. Pediatr Blood Cancer. 2009;52(7):838\u201341. Available from:. https:\/\/doi.org\/10.1002\/pbc.21974.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"5998_CR23","doi-asserted-by":"publisher","first-page":"e27781","DOI":"10.1002\/pbc.27781","volume":"66","author":"B Allemang","year":"2019","unstructured":"Allemang B, Allan K, Johnson C, Cheong M, Cheung P, Odame I, et al. Impact of a transition program with navigator on loss to follow-up, medication adherence, and appointment attendance in hemoglobinopathies. Pediatr Blood Cancer. 2019;66(8):e27781 Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/pbc.27781.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"5998_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/MPH.0b013e3181acd889","volume":"31","author":"LE Crosby","year":"2009","unstructured":"Crosby LE, Modi AC, Lemanek KL, Guilfoyle SM, Kalinyak KA, Mitchell MJ. Perceived barriers to clinic appointments for adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2009;31(8):571\u20136 Available from: http:\/\/journals.lww.com\/00043426-200908000-00008.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3\u20134","key":"5998_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12288-008-0005-z","volume":"23","author":"AV Shrikhande","year":"2007","unstructured":"Shrikhande AV, Dani AA, Tijare JR, Agrawal AK. Hematological profile of sickle cell disease in central India. Indian J Hematol Blood Transfus. 2007;23(3\u20134):92\u20138 Available from: http:\/\/link.springer.com\/10.1007\/s12288-008-0005-z.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"5998_CR26","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4081\/hr.2012.e8","volume":"4","author":"SS Rao","year":"2012","unstructured":"Rao SS, Goyal JP, Raghunath S, Shah VB. Hematological profile of sickle cell disease from South Gujarat, India. Hematol Rep. 2012;4(2):e8 Available from: http:\/\/www.pagepress.org\/journals\/index.php\/hr\/article\/view\/4064.","journal-title":"Hematol Rep"},{"key":"5998_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/JBM.S169872","volume":"9","author":"C Antwi-Boasiako","year":"2018","unstructured":"Antwi-Boasiako C, Ekem I, Abdul-Rahman M, Sey F, Doku A, Dzudzor B, et al. Hematological parameters in Ghanaian sickle cell disease patients. J Blood Med. 2018;9:203\u20139 Available from: https:\/\/www.dovepress.com\/hematological-parameters-in-ghanaian-sickle-cell-disease-patients-peer-reviewed-article-JBM.","journal-title":"J Blood Med"},{"issue":"1","key":"5998_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/1756-0500-5-396","volume":"5","author":"A Akinbami","year":"2012","unstructured":"Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5(1):396 Available from: https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-396.","journal-title":"BMC Res Notes"},{"key":"5998_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/JBM.S148463","volume":"8","author":"AE Ahmed","year":"2017","unstructured":"Ahmed AE, Ali YZ, Alsuliman A, Albagshi J, Al Salamah M, Elsayid M, et al. The prevalence of abnormal leukocyte count, and its predisposing factors, in patients with sickle cell disease in Saudi Arabia. J Blood Med. 2017;8:185\u201391 Available from: https:\/\/www.dovepress.com\/the-prevalence-of-abnormal-leukocyte-count-and-its-predisposing-factor-peer-reviewed-article-JBM.","journal-title":"J Blood Med"},{"issue":"4","key":"5998_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/archpedi.1978.02120290068013","volume":"132","author":"GR Buchanan","year":"1978","unstructured":"Buchanan GR. Leukocyte Counts in Children With Sickle Cell Disease. Am J Dis Child. 1978;132(4):396 Available from: http:\/\/archpedi.jamanetwork.com\/article.aspx?doi=10.1001\/archpedi.1978.02120290068013.","journal-title":"Am J Dis Child"},{"issue":"9","key":"5998_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4103\/0019-5359.108955","volume":"65","author":"O Emmanuelchide","year":"2011","unstructured":"Emmanuelchide O, Charle O, Uchenna O. Hematological parameters in association with outcomes in sickle cell anemia patients0. Indian J Med Sci. 2011;65(9):393 Available from: http:\/\/www.indianjmedsci.org\/text.asp?2011\/65\/9\/393\/108955.","journal-title":"Indian J Med Sci"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-020-05998-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T08:34:46Z","timestamp":1607934886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05998-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5998"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05998-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16167\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16167\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16167\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16167\/v4","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Senate Research and Publications Committee of the Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania approved the study (Ref. No.DA.282\/298\/01.C\/). Permission to publish the secondary data was obtained from Principle Investigator of MUHAS Sickle Cell Program.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1141"}}